Sign In
Buy THTX
$3.39
+0 (+0%)
At Close: Dec 24, 2025
Theratechnologies Announces Update on its Preclinical Oncology Research Program
09:36am, Friday, 22'nd Mar 2024
Company continues to shift to commercial focus as it seeks partners to advance R&D MONTREAL, March 22, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (T
Theratechnologies Appoints Jordan Zwick to its Board of Directors
08:00pm, Thursday, 21'st Mar 2024
MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
07:30am, Thursday, 21'st Mar 2024
MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau
04:34pm, Thursday, 29'th Feb 2024
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA
07:30am, Tuesday, 27'th Feb 2024
MONTREAL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies (THTX) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:51am, Monday, 26'th Feb 2024
Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are st
Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript
12:41pm, Wednesday, 21'st Feb 2024
Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance
07:30am, Wednesday, 21'st Feb 2024
MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
MONTREAL, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
07:30am, Tuesday, 06'th Feb 2024
MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Why Is Theratechnologies (THTX) Stock Down 22% Today?
09:11am, Thursday, 26'th Oct 2023
Theratechnologies (NASDAQ: THTX ) stock is dropping on Thursday after the biopharmaceutical company announced a proposed public share offering. Theratechnologies is selling 12.5 million shares of TH
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
07:00am, Wednesday, 20'th Sep 2023
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
04:15pm, Monday, 18'th Sep 2023
MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
01:57pm, Thursday, 07'th Sep 2023
MONTREAL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update
07:30am, Thursday, 29'th Jun 2023
MONTREAL, June 29, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
